Locations
Taipei City, Taiwan · Taipei, Taiwan
industry
Biotechnology
Size
11-50 employees
Stage
Series B
founded in
2009
Steminent Biotherapeutics Inc. is the leading stem cell clinical development company in Taipei, with subsidiaries in San Diego and Shanghai, dedicated to the development of novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. Steminent utilizes advanced, proprietary processes and know-how to isolate, purify, amplify, and manufacture standardized stem cell products of the highest quality for research and clinical development in multiple indications. Steminent’s Stemchymal® allogeneic cell therapy R&D program has generated a portfolio of clinical stage therapeutic candidates for multiple diseases including: Phase II; Spinocerebellar Ataxia (PolyQ SCA), Phase I; Osteoarthritis of the knee, and Phase I: Acute Liver Failure. 幹細胞醫藥產業先驅的仲恩生醫,以推動異體間葉幹細胞治療為核心,擁有世界一流的幹細胞研發團隊與技術。獨家核心技術平台Stemchymal®,以領先全球的幹細胞分離、純化、增生技術,應用於自體及異體的脂肪間葉幹細胞治療。 仲恩生醫以最嚴謹的製藥規範與品質管理,不斷累積科學實證,並透過國內外頂尖醫學中心臨床試驗證實仲恩生醫幹細胞產品的安全與療效。除此,仲恩生醫透過與臨床醫師及國內外合作夥伴緊密的合作,持續地針對臨床未被滿足的需求,持續開發。
Is this your company?
Something looks off?
On-site & Remote